HIV/AIDS Treatment Guidelines | Clinicalinfo.HIV.gov
2024年6月27日 · HIV/AIDS Treatment and Prevention Guidelines, prepared by expert panels, are available for download for health care providers and consumers. Learn more here.
What's New: Adult and Adolescent ARV HIV Clinical Guidelines | NIH
2024年9月12日 · These guidelines were updated by the U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) based on key new clinical evidence on the use of antiretroviral therapy (ART) …
Guidelines for the Prevention and Treatment of Opportunistic …
This table provides chemoprophylaxis recommendations to prevent the first episode of opportunistic disease in adults and adolescents with HIV.
Clinicalinfo | Information on HIV/AIDS Treatment, Prevention and ...
Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.
Initiation of Antiretroviral Therapy | NIH - Clinicalinfo
2019年12月18日 · Initiating Antiretroviral Therapy. ART is recommended for all individuals with HIV to reduce the morbidity and mortality associated with HIV infection (AI) and to prevent HIV transmission to sexual partners and infants (AI). ART should be initiated as soon as possible after HIV diagnosis (AII).
Guidelines for the Use of Antiretroviral Agents in Adults and ...
These guidelines focus on antiretroviral therapy (ART) for adults and adolescents with HIV. For a more detailed discussion on the use of ART in children and prepubertal adolescents (those with sexual maturity ratings of 1 to 3), clinicians should refer to the Pediatric Antiretroviral Guidelines .
What's New: Adult and Adolescent OIs HIV Clinical Guidelines | NIH
2024年10月29日 · Adult and Adolescent Opportunistic Infection Archived Guidelines. Updates to the clinical guidelines for the treatment and prevention of opportunistic infections in adults and adolescents with HIV.
%PDF-1.7 %âãÏÓ 47289 0 obj >stream hÞÔ{koœ7–æ_© vñ~Y4 øÒIŒm§ qf3…ú X G Y2¤J¶ýï÷yžCV½*Ië$ØY`!è%‹×CòðÜ™rëeåV i]yŸ”k+ ³r} ZA®;´‰]9¿JÅ) V©Gåâ* k—V¹X»¼*ÅÊʪ– \]µÜ”k«îm”Žy §c ï%¨ ÷ÌÛ”> ?†ð ù&@;¾Á¹æ•Ï« ZÓ ¾0ß¼®Bt^`ú†| 6 – K €Á!ßl¡Á¯B ¶¬ Ï ù¸ ÙY߀y³w‚ %Ègk_˜oyõ—¿¬ ...
2023年12月6日 · HIV-2 Infection section of the guidelines has been updated with the following key information: • Because HIV-2 is intrinsically resistant to non-nucleoside reverse transcriptase inhibitors, the long-acting injectable regimen of cabotegravir (CAB) and rilpivirine is not recommended for
Guidelines for the Use of Antiretroviral Agents in Adults and ...
2024年9月12日 · View the clinical guidelines for the initial selection and prescription of antiretroviral regimens in adults and adolescents with HIV.